News and Announcements
Cellmid FY16 Update: Strong Revenue Growth, Full Range Launched, Presence Built in Major Markets
- Published July 12, 2016 5:30PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Cellmid, a life sciences accelerator, continued to build its consumer health business during FY2016 and is on track to deliver strong revenue growth for the period.
The Company launched its full range of clinically validated hair growth products, evolis®, in Australian pharmacies in May 2015, and doubled its Japanese distribution.
Most recently, Cellmid launched an evolis® Professional range for the hair salon market, opening up major opportunities in anti-aging hair care.
With its category leading product, Cellmid started to build presence in major markets (USA, China) in 2016, planning commercial launches in the next 12 to 18 months in these regions.
ABOUT CELLMID LTD
Cellmid (ASX: CDY) develops innovative therapies and diagnostics for cancer, inflammation and heart attack. CDY has the largest global IP portfolio related to growth factor midkine (MK). Its most advanced program is for MK antibodies targeting cancer/inflammation. CDY is also developing MK protein to treat heart attack and other ischemia. CDY’s first product is a blood test measuring serum MK. MK is a powerful biomarker of early cancer. CDY’s subsidiary Advangen develops and sells scientifically validated products to prevent and treat hair loss with products that have a well understood, safe and novel mechanism (inhibiting FGF-5). Two product ranges are on market, for pharmacies (évolis®) and professional hair salons (Jo-Ju® & Lexilis®).
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
